Tag Archives: agent

New anti-VEGF agent could reduce treatment burden for patients with wet AMD

Novartis proprietary anti-VEGF agent RTH258 (brolucizumab) appears to be noninferior to aflibercept for treatment of neovascular age-related macular degeneration (AMD), according to results from 2 ongoing phase 3 studies.[Read More ] Source: Daily Dose of Eye Care